Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
Dr. Denise Galloway elected Fellow of the American Association for Cancer Research Academy
Cancer biologist contributed basic and translational insights that made the cancer-preventive HPV vaccine possible
Tip Sheet: Cancer-busting broccoli sprout pills in space, trauma and healing among Indigenous people, how to boost HPV vaccinations
Summaries of recent Fred Hutch research findings and other news
Learning to trust science with your life
Diseases like cancer and COVID-19 can be scary; leaning into the science helps you feel more empowered
Correlation is not (necessarily) causation
Or, how we know herpes doesn’t cause cervical cancer — and HPV does
Dr. Denise Galloway, expert in cancer-causing viruses, named 'Woman of Influence'
Puget Sound Business Journal recognizes researcher's impact, scientific leadership
How to talk to parents about HPV vaccines
Fred Hutch public health researcher shares science-based tips to help doctors navigate crucial cancer-prevention conversations
Drs. Jeanne Ting Chowning, Denise Galloway receive Seattle AWIS awards
Honored for excellence in STEM education/outreach, science advancement and leadership
Drs. Denise Galloway and Hans-Peter Kiem receive endowed chairs
Paul Stephanus Memorial Endowed Chair to Galloway; Stephanus Family Endowed Chair for Cell and Gene Therapy to Kiem
Galloway and Hartwell to enter Washington Life Science Hall of Fame
Awards recognize power of basic research, leadership in driving advances for patients
High-Risk HPV Impairs the Homologous Recombination Pathway
From the Galloway Lab, Human Biology Division
Galloway receives NCI Outstanding Investigator Award
Leader in HPV research will work to improve detection, prevention and treatment of virally caused cancers
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Fred Hutch epidemiologists receive $2.5M grant for first-ever study of therapeutic use for HPV vaccine
Could the preventive vaccine also be a therapy for anogenital precancers?
Bezos family gives $35 million to Fred Hutch
‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients
Health disparities workshops build bridges to better serve marginalized communities
Health disparities workshops build bridges to better serve marginalized communities
Nearly half of U.S. men actively infected with HPV, study finds
HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated
HPV vaccine boosts immune memory
A single dose of the HPV vaccine can strengthen immune memory in people who’ve previously been infected with HPV — and potentially help prevent re-infection
Good News at Fred Hutch
Celebrating faculty and staff achievements
69 cancer centers join to urge increased HPV vaccination
U.S. cancer centers unanimously call for increase in vaccine use for cancer prevention
HPV vaccine uptake highest in Hispanic, low-income communities
Where you live matters for cancer-preventing shot, new study suggests